Elevated levels of ΔFosB are associated with a loss of FosB function, which results in the early development of dyskinesia and unstable firing rate changes during the ON phase in L-DOPA-treated animals [86]. The gene discussed is FOSB; the disease is drug-induced dyskinesia.